Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SPYRAL GEMINI Pilot Study

NCT: NCT06907147 · RECRUITING

NCT IDNCT06907147
StatusRECRUITING
Start Date2025-05-01
Completion2029-12-22
SponsorMedtronic Vascular (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑